Gram-negative bacteria are surrounded by an inner cytoplasmic membrane and by an outer membrane, which serves as a protective barrier to limit entry of many antibiotics. The distinctive properties of the outer membrane are due to the presence of lipopolysaccharide 1 . This large glycolipid, which contains numerous sugars, is made in the cytoplasm; a complex of proteins forms a membrane-to-membrane bridge that mediates transport of lipopolysaccharide from the inner membrane to the cell surface 1 . The inner-membrane components of the protein bridge comprise an ATP-binding cassette transporter that powers transport, but how this transporter ensures unidirectional lipopolysaccharide movement across the bridge to the outer membrane is unknown 2 . Here we describe two crystal structures of a five-component innermembrane complex that contains all the proteins required to extract lipopolysaccharide from the membrane and pass it to the protein bridge. Analysis of these structures, combined with biochemical and genetic experiments, identifies the path of lipopolysaccharide entry into the cavity of the transporter and up to the bridge. We also identify a protein gate that must open to allow movement of substrate from the cavity onto the bridge. Lipopolysaccharide entry into the cavity is ATP-independent, but ATP is required for lipopolysaccharide movement past the gate and onto the bridge. Our findings explain how the inner-membrane transport complex controls efficient unidirectional transport of lipopolysaccharide against its concentration gradient.
2.85 Å and 3.2 Å resolution, respectively ( Fig. 1b , Extended Data Fig. 2 , Supplementary Table 1 ).
LptF and LptC form a continuous β-jellyroll via an edge-to-edge interaction between their C-and N-terminal β-strands (Fig. 1b) , and there are numerous contacts between side chains on the convex surfaces of the LptF and LptG β-jellyroll sheets. The transmembrane anchor of LptC interdigitates between LptG transmembrane domain (TM)1 and LptF TM5 (Fig. 1b, c) . To our knowledge, no other ABC system contains a transmembrane helix from another protein incorporated directly into the transporter 9, 21 . Below we show that this helix regulates transport activity.
To probe the in vivo relevance of the crystal structures, we incorporated a photocrosslinkable unnatural amino acid (p-benzoylphenylalanine, pBPA) at multiple sites in LptF, LptG and LptC 22 and tested for protein-protein contacts. We replaced several residues at the interface 1 Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA. 2 between LptC and LptF, and at the terminal β-strand of the LptG β-jellyroll ( Fig. 2a ). We found extensive crosslinks between LptC and LptF, but the only crosslink between LptC and LptG was from a residue on the convex side of LptC that faces LptG (Fig. 2b , Extended Data Fig. 4a ). We conclude that the marked asymmetry observed in the crystal structure is physiologically relevant. LptC creates a single pathway for entry and movement of LPS onto the bridge. Although LptC-mutant bacteria that lack the transmembrane helix can survive in the laboratory, only full-length LptC occurs naturally, which implies a strong selection for the transmembrane helix 23, 24 . To probe the role of the LptC transmembrane helix, we compared the functions of LptB 2 FG complexes that contain either no LptC, wild-type LptC or LptC with the transmembrane helix removed (hereafter LptC(ΔTM)) in proteoliposomes. LPS transport to LptA was greatly diminished in the absence of LptC, but LptC(ΔTM)-which stably associates with LptB 2 FG (Extended Data Fig. 4b )-supported transport to a degree comparable to that of full-length LptC (Fig. 2c ). However, even when a large excess (tenfold) of LptC(ΔTM) was used, the ATPase activity of the LptB 2 FG-LptC(ΔTM) complex was markedly higher than that of LptB 2 FGC 4 (Fig. 2d, Extended Data Fig. 4c ). Because LptB 2 FGC uses less ATP to transport LPS than LptB 2 FG-LptC(ΔTM), we conclude that the transmembrane domain of LptC modulates ATP hydrolysis to achieve more-efficient coupling of ATP hydrolysis and LPS movement.
Previous structures of LptB 2 FG suggested an alternating-access model with two possible gates on opposite sides of the transporter for entry of LPS into the cavity 19, 20 (Fig. 2e , left, Extended Data Fig. 5 ). In the absence of LptC, these entry paths are structurally similar, and are related by two-fold rotational pseudosymmetry. However, the presence of the LptC transmembrane helix breaks the symmetry and differentiates the potential points of entry. Our structures define a single path for LPS entry into the cavity between LptG TM1 and LptF TM5 where the transmembrane segment of LptC is located; this path is directly aligned with the concave surface of the continuous β-jellyroll formed by the interaction of LptF and LptC. Entry between LptG TM5 and LptF TM1 is prevented by the steric barrier created by the convex surface of the continuous LptC-LptF β-jellyroll ( Fig. 2e, right) .
To probe how LPS moves into the cavity and up to LptC, we used in vivo photocrosslinking to determine where LPS binds 10 . We trapped LPS in two distinct regions of the transporter (Fig. 3 , Extended Data Figs. 6, 7): at the base of the transport machine between the interdigitated LptC helix, LptG TM1 and LptF TM5 ( Fig. 3a, b , Extended Data Fig. 6c, d) , and at the interface of the β-jellyroll between LptF and LptC ( Fig. 3c , Extended Data Fig. 7 ). We did not observe crosslinks to LPS at the alternate entry point between LptG TM5 and LptF TM1 (Extended Data Fig. 6e ). The crosslinks at the base of the transporter indicate how LPS enters the cavity; we trapped LPS at two sites, one located just outside the cavity as defined by crosslinks to LptC M19pBPA and LptF S315pBPA, and one located inside the cavity as defined by LptC G21pBPA and LptG S30pBPA. The crosslinks at the interface between the β-jellyrolls of LptF and LptC (LptC F78pBPA and LptF R223pBPA; Fig. 3b , c, Extended Data Fig. 6a ) indicate how LPS might move from the cavity onto the bridge, and are also consistent with the single path for movement defined by the structures.
We compared in vivo crosslinking intensities at the different LPSbinding sites ( Fig. 3b ) in wild-type and catalytically dead complexes to probe which steps in LPS transport are ATP-dependent. Crosslinking was negligible to the β-jellyroll of LptC and LptF in the complex that contained the inactive LptB(E163Q) 11 ATPase, but was much stronger to binding sites at the base of the cavity. By contrast, the LPS crosslinks to the β-jellyroll of LptC and LptF were much stronger in complexes that contain wild-type LptB. These results suggested that entry into the cavity of the LptB 2 FGC transporter does not require ATP hydrolysis, but accumulation of LPS in the β-jellyroll does. Increased crosslinking intensities at the base of the cavity for the inactive transporter is likely to reflect the build-up of LPS in the inner membrane owing to impaired transport 12 .
We performed in vitro crosslinking experiments to clarify whether entry into the cavity or extraction from the membrane requires ATP. Crosslinking to LPS at LptC G21pBPA, at the base facing the interior of the cavity, was observed in the absence of ATP (resting state) and in a pre-hydrolysis state in which ATP is present but hydrolysis is not possible owing to a lack of Mg 2+ (Fig. 3d , +EDTA). Crosslinking to LptC F78pBPA in the β-jellyroll was not observed under these conditions. Similar results were obtained for the complex containing LptB(E163Q) or when the non-hydrolysable ATP analogue AMPPNP was used (Extended Data Fig. 6c ). Weak crosslinking to LptC F78pBPA was observed in the presence of ATP and vanadate ( Fig. 3d Letter reSeArCH with a transporter that can extract but cannot turn over continually owing to inhibition by ADP-vanadate. In sum, these results show that entry into the transporter cavity does not require ATP; however, ATP is required to extract LPS out of the membrane.
The LPS transporter presents a problem not found in other ABC transporter systems, because LPS in the bridge can potentially flow backward when the cavity reopens. Unless the rate of entry of LPS into the cavity is much faster than backward flow, there must be a mechanism to prevent the latter or transport would be inefficient. A notable feature of our LptB 2 FGC crystal structures is that the β-jellyroll of LptF exists in two structurally distinct states: in the E. cloacae complex it is open ( Fig. 4a, b ), whereas in the V. cholerae complex it is closed ( Fig. 4b , Extended Data Fig. 8 ). To determine whether transport requires access to the open state, we introduced a pair of cysteines capable of forming a disulfide bond into LptF to trap it in the closed state ( Fig. 4c ). Cells that express LptF containing the single cysteine mutations were viable, but those that produce the double-cysteine mutant-LptF(Cys2)were nonviable, even when cellular levels were similar to those of wild-type LptF (Extended Data Fig. 9a -c). LptF(Cys2) was dominant negative, which implies that the mutant LptF formed a non-functional complex with the other inner-membrane Lpt components (Extended Data Fig. 9d ). We successfully purified LptB 2 F(Cys2)GC complexes (Extended Data Fig. 9e ), which shows that the loss of viability was not due to an assembly defect. Using an in vitro LPS-transport assay ( Fig. 4d ), we observed transport by the LptB 2 F(Cys2)GC mutant complex only upon the addition of DTT ( Fig. 4e ), which reduced the disulfide bond and allowed LptF to access an open state. By contrast, ATP hydrolysis occurred regardless of whether the gate in LptF was open or closed (Extended Data Fig. 9f ), which indicates that gate opening is not directly coupled to ATP hydrolysis. We infer that movement of the substrate, driven by ATP binding or hydrolysis, pushes the gate open. Spontaneous gate closure behind the substrate provides a mechanism to reduce the rate of backward flow when the cavity reopens.
On the basis of the structural and functional studies reported here, we propose the following model for LPS transport. First, newly synthesized LPS present in the inner membrane binds at the entry point defined by the LptC transmembrane segment intercalated between LptG TM1 and LptF TM5 (Fig. 4f ), and ATP-independent entry of LPS into the cavity past the LptC transmembrane segment occurs 25 . ATP-dependent cavity constriction then provides the force to push LPS out of the membrane. The LptC transmembrane helix coordinates ATP hydrolysis with extraction from the membrane, and this role in transport efficiency apparently provides such an important fitness advantage that it is conserved in the wild even though it can be bypassed in the laboratory under certain conditions 23, 26 . The gate in the β-jellyroll of LptF also improves transport efficiency by preventing backward movement of LPS into the membrane as the cavity reopens, ensuring unidirectional traffic from LptC to LptA and through LptDE to the outer membrane.
As correct LPS transport is critical for survival, the structures and functional information reported here may lead to new strategies for the development of antibiotics. Such strategies may include binding tightly to LPS in the cavity of the machinery to jam it, or disrupting interfaces between components of the machinery to reduce efficiency of transport. Compounds that impair outer-membrane assembly would make Gram-negative bacteria sensitive to many antibiotics that cannot usually penetrate into the bacteria.
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Cloning, expression and purification of LptB 2 FGC homologues. Genes encoding LptB, LptC, and LptFG were amplified by PCR from E. cloacae subspecies cloacae (ATCC 13047) and Vibrio cholerae C6706 genomic DNA. LptB and LptFG PCR products were inserted into pCDFduet by Gibson assembly (New England Biolabs) to generate plasmids analogous to those previously used for the E. coli homologues 10 . LptC PCR products were subcloned into pET22/42 and then inserted into pBADHisA, with a C-terminal thrombin cleavage site and His 7 tag. Oligonucleotide primers were purchased from IDT or Eton Biosciences, and are listed in Supplementary Table 1 . Plasmids pBADHisA-LptC-thrombin-His 7 and pCDFduet-LptB-LptFG were then co-transformed into C43 E. coli.
For overexpression of E. cloacae LptB 2 FGC-His complexes, overnight cultures of C43 E. coli containing pBADHisA-LptC-thrombin-His 7 and pCDFduet-LptB-LptFG were diluted 1:100 into M9 minimal medium (Cold Spring Harbour) supplemented with trace elements, 50 μg/ml carbenicillin and 50 μg/ml spectinomycin. These cultures were grown at 37 °C, with shaking at 200 r.p.m. to A 600 nm = 1.0, then cooled to 30 °C, and induced by addition of 200 μM isopropylβ-d-thiogalactoside (IPTG) and 0.02% l-arabinose. After 12 h expression, cells were collected by centrifugation and resuspended in buffer containing 20 mM Tris-HCl (pH 7.4), 300 mM NaCl, 0.2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF) and supplemented with 100 μg/ml lysozyme, 50 μg/ml DNase I and cOmplete protease inhibitor tablets (Sigma). Resuspended cells were lysed by a 3× passage through an Emulsiflex C3 homogenizer (Avestin) at 15,000 p.s.i. Unbroken cells were removed from the lysate by centrifugation at 12,000g, 4 °C for 10 min, and then membranes were pelleted by ultracentrifugation at 100,000g, 4 °C for 1 h in a Beckman 45Ti rotor. Membrane pellets were resuspended in solubilization buffer (20 mM Tris (pH 7.4), 300 mM NaCl, 10% v/v glycerol, 5 mM MgCl 2 , cOmplete protease inhibitor), homogenized using an IKA T18 basic UltraTurrax, supplemented with 1% w/v n-dodecyl-β-d-maltoside (DDM; Anatrace) and 2 mM ATP, and then rocked at 4 °C for 2 h. Insoluble cell debris were removed by ultracentrifugation 100,000g, 4 °C for 30 min and the clarified, solubilized membranes rocked with Ni-NTA agarose (Qiagen) in a gravity flow column for 2 h. To generate inactive variants of LptB 2 FGC-His 7 complexes, site-directed mutagenesis was used to introduce a Glu to Gln substitution at LptB E163 in pCD-Fduet-LptB-LptFG. LptB E163 is strictly conserved in all known homologues of LptB 11 , and is the catalytic base that deprotonates water for nucleophilic attack on the terminal phosphate of ATP, a mechanism that is conserved in all ABC systems 8 . Purification of LptB(E163Q) 2 FGC-His 7 complexes was carried out in the same manner as the corresponding wild-type complexes, except that ATP was spiked into the Ni-NTA eluate to a final concentration of 2 mM before the first concentration step. Crystallization of LptB 2 FGC. Wild-type E. cloacae LptB 2 FGC was crystallized by the vapour diffusion method in hanging drops at 4 °C. Protein samples with the tag cleaved were concentrated to 14 mg/ml, supplemented with 2 mM Na-novobiocin, and mixed at a 2:1 protein:precipitant ratio with a precipitant solution consisting of 500 mM Li 2 SO 4 , 100 mM MES (pH 6.5) and 21% v/v PEG400. We had previously shown novobiocin binds to E. coli LptB 2 FGC and solved a co-crystal structure of LptB alone bound to novobiocin 27 , and so thought that it might stabilize a conformation of the full complex. In sparse-matrix screening with E. cloacae LptB 2 FGC we found several conditions that were dependent on the presence of Na-novobiocin in the protein sample. In this form, however, novobiocin is not bound in a functionally important site but is instead involved forming crystal contacts (see below). Streak-seeding into freshly set drops significantly improved crystal morphology. Crystals grew to full size within three weeks and were then dehydrated by increasing the concentration of PEG400 in the reservoir by 2% per day up to 35% v/v PEG 400. Crystals were frozen directly from drops or briefly cryoprotected in a solution containing 500 mM NaCl, 2 mM Na-novobiocin, 100 mM MES (pH 6.5) and 35% v/v PEG400 before being flash-frozen and stored in liquid nitrogen.
Inactive V. cholerae LptB(E163Q) 2 FGC was crystallized by vapour diffusion in sitting drops at 4 °C. Protein samples were concentrated to 16 mg/ml, supplemented with 5 mM Na-ATP and 2 mM EDTA, and mixed at a 2:1 protein:precipitant ratio with a precipitant solution consisting of 200 mM CaCl 2 , 100 mM Tris-HCl (pH 8.5), and 40% v/v PEG400. Crystals appeared after one to two weeks and grew to full size within six weeks. Crystals could be obtained from these conditions without ATP in the sample or in earlier purification steps; however, crystals obtained in this way were much lower quality. Likewise, crystals of similar morphology could also be obtained using wild-type LptB 2 FGC and the non-hydrolysable ATP analogue, AMPPNP. Crystals could be collected directly from drops and flash-frozen in liquid nitrogen, but addition to the drop of ~10 μl of a cryo-solution containing 41% v/v PEG400, 200 mM CaCl 2 , 300 mM NaCl and 100 mM Tris-HCl (pH 8.5) was often necessary to facilitate freezing of long, fragile plates. Data collection and structure determination. Diffraction data were collected at Argonne National Laboratory beamline GM/CA 23-ID-D at wavelength 1.033 Å for E. cloacae LptB 2 FGC crystals, and NE-CAT beamline 24-ID-E at 0.979 Å for V. cholerae LptB(E163Q) 2 FGC crystals. Data were integrated in XDS 28 and scaled in the CCP4 29 suite program AIMLESS 30 . Molecular replacement for the E. cloacae data was performed in Phaser 31 using the transmembrane domains of K. pneumoniae LptB 2 FG (PDB ID 5L75) 19 , two copies of E. coli LptB (PDB ID 6B89) 27 and one copy of E. coli LptC (PDB ID 3MY2) 18 . After one round of refinement in Phenix 32 , transmembrane helix of LptC as well as most of the periplasmic domains of LptF and LptG were built manually in Coot 33 using 5L75 and 5X5Y to guide assignment of amino acid identity. At that point it became clear the LptC periplasmic domain was misplaced by Phaser, with register of the strands in the β-jellyroll being off by one full strand, as LptC residues 1-57 were not present in either of the previously solved structures (3MY2 and 4B54) but residues 42-57 comprise the β-strand at the interface between LptC and LptF. Nonetheless in this structure, LptC residues 25-38 could not be resolved. Further model building and refinement were carried out alternately in Coot and phenix.refine 34 . Non-crystallographic symmetry restraints were used early in refinement to constrain the two copies of LptB 2 FGC in the asymmetric unit but were not used between the two copies of LptB with each complex. The final model contained 94.45%, 5.47%, and 0.08% in the favoured, allowed and outlier regions of the Ramachandran plot, respectively.
Given the dependence of crystal formation on the presence of novobiocin in the protein sample, we had hoped to see it bound at the interface between LptB and LptFG, as observed in our previous work (see PDB IDs 6B89 and 6B8B) 4 . There was no unexplained electron density near either copy of residue LptB(F90), but one novobiocin molecule could be accommodated at the interface between the two non-crystallographically symmetric copies of LptB 2 FGC (Extended Data Fig. 10a ) and thereby explain the dependence of crystallization on novobiocin.
The structure of V. cholerae LptB(E163Q) 2 FGC was determined by molecular replacement using the E. cloacae structure as a search model. Significantly different conformations of the periplasmic domains of LptF, LptG, and LptC required manual rebuilding of these regions. In the structure, the residues connecting the transmembrane helix of LptC to the periplasmic β-jellyroll domain were fully resolved, although a few loops between transmembrane helices of LptF and LptG remained disordered. No density corresponding to bound nucleotides could be observed. Density probably corresponding to bound detergent molecules and ordered PEG molecules could be found surrounding the transmembrane helices and nucleotide binding domains, respectively (Extended Data Fig. 10b, c) . We further observed large, unexplained areas of electron density in the lumen between the transmembrane helices (Extended Data Fig. 10d, e ). Some of this could correspond to bound detergent or PEG molecules; however, the size, continuity and distance from the protein suggest that this electron density is more likely to correspond to lowoccupancy or partially disordered LPS molecules that co-purified with the LptB 2 FGC complex (Extended Data Fig. 10d, e ). The final refined model contained 95.64%, 4.36% and 0.0% in the favoured, allowed and outlier regions of the Ramachandran plot, respectively. In vivo photocrosslinking experiments. To search for interactions between LptB 2 FGC components, as well as between Lpt proteins and LPS, in vivo photocrosslinking experiments were performed as previously described 10 , with minor modifications. BL21(DE3) E. coli strains were transformed with pSup-BpaRS-6TRN 22 , pBADHisA-LptC-thrombin-His 7 , and pCDFduet-LptB(WT or E163Q)-LptFG, with amber (TAG) codons introduced at one position in either LptF, LptG or LptC. Fifty-millilitre cultures of these strains were grown at 37 °C in LB containing 50 μg/ml spectinomycin, 50 μg/ml carbenicillin, 30 μg/ml chloramphenicol and 0.7 mM pBPA (BaChem). When the cultures reached A 600 nm ~ 0.8, expression of pBPA-substituted LptB 2 FGC complexes was induced by addition of 20 μM IPTG and 0.02% l-arabinose. After 2 h expression at 37 °C, cultures were divided into UV− and UV+ samples, the former set aside, and the later exposed to UV light (λ = 365 nm) at room temperature for 5 min.
To facilitate western blot analysis of Lpt-Lpt and Lpt-LPS adducts, pBPA substituted LptB 2 FGC-His complexes were solubilized and purified by nickel-affinity chromatography. First, cells from both UV− and UV+ samples were pelleted by centrifugation (5,000g, 10 min, 4 °C), resuspended in 2 ml buffer A (20mM Tris (pH 8.0), 300 mM NaCl, 15 mM imidazole, 5 mM MgCl 2 , 1% w/v Anzergent 3-14 (Anatrace) and 1 mM PMSF) containing 100 μg/ml lysozyme and 50 μg/ml DNaseI, and then disrupted by three freeze-thaw cycles alternating between liquid nitrogen and an ice water bath. After the third freeze-thaw cycle, samples were incubated on ice for 30 min, at which point they had turned from cloudy to clear, and insoluble cell debris were removed by centrifugation for 30 min at 18,500g. Solubilized supernatants were then applied to Ni-NTA resin (250 μl resin per sample) pre-equilibrated with buffer A. After flow-through, the resin was washed once with 1 ml buffer A and twice with 5 ml wash buffer containing 20 mM Tris (pH 8.0), 300 mM NaCl, 0.1% w/v Anzergent 3-14 and 20 mM imidazole. His-tagged LptB 2 FGC complexes were eluted with 2 × 750 μl wash buffer containing 200 mM imidazole. To concentrate the samples, proteins were precipitated from the eluate by addition of 10% w/v trichloroaceticacid, incubated on ice 30 min, pelleted at 21,500g for 30 min at 4 °C; following, the supernatant was aspirated off and pellets rinsed with 500 μl cold acetone, and then pelleted again 21,500g for 30 min at 4 °C. Finally, the acetone was aspirated off, and the protein pellet resuspended in 80 μl SDS gel-loading buffer.
For western blot analysis, these samples were boiled, separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to PVDF membranes (Bio-Rad). Detection of protein bands was achieved by labelling with rabbit antisera against LptF 23 , LptG 23 and LptC 35 followed by donkey anti-rabbit HRP conjugate secondary antibody (GE Amersham), or by mouse anti-His 5 -HRP conjugate (Qiagen). Lpt-LPS adducts were detected by anti-LPS core mouse monoclonal antibody-HRP conjugate (Hycult Biotechnology). Bands were visualized using ECL Prime Western Blotting Detection Reagent (GE Amersham), and imaged using an Azure c600 (Azure Biosystems).
Reconstitution of LPS release to LptA by E. cloacae and V. cholerae LptB 2 FGC complexes.
Genes that encode LptA homologues were PCR-amplified from V. cholerae and E. cloacae genomic DNA and incorporated into pET22b in a manner that replaced the native signal sequences with the plasmid-encoded pelB leader and added a His 6 tag to the C terminus. Amber mutations for pBPA incorporation were made at positions which aligned with E. coli LptA(I36) (Extended Data Fig. 3 ) to generate V. cholerae pET22b-pelBss-LptA(V34pBPA)-His 6 and E. cloacae pET22b-pelBss-LptA(I36pBPA)-His 6 . Both were purified as previously described for E. coli LptA(I36pBPA)-His 6 4,10 .
To test the activity of purified V. cholerae and E. cloacae LptB 2 FGC complexes, we reconstituted LPS release from liposomes to soluble LptA as described 16 with minor modifications (Extended Data Fig. 1b ). In brief, purified LptB 2 FGC complexes, containing wild-type LptB or inactive LptB(E163Q), were incorporated into liposomes composed of E. coli polar lipids (Avanti Polar Lipids) and Ra-LPS (Sigma) by the detergent-dilution method. Proteoliposome stock solutions in 20 mM Tris-HCl (pH 8.0), 150 mM NaCl and 10% v/v glycerol were mixed on ice with LptA(XpBPA)-His, 1 M Tris-HCL pH 8.0, 5 M NaCl, glycerol and either ATP-MgCl 2 or ATP-EDTA, such that the final concentrations of each were 60%v/v proteoliposomes, 2 μM LptA, 500 mM NaCl, 50 mM Tris-HCl (pH 8.0), 5 mM ATP, and 2 mM MgCl 2 or 2 mM EDTA. Total volume was calculated such that 30 μl could be used per sample per time point. Stocks of ATP-Mg and ATP-EDTA were pre-mixed and added last, and after their addition the mixtures were moved from ice to 30 °C to initiate LPS transport. At the specified time points, 30-μl aliquots were transferred from the reaction mixtures to a 96-well plate on ice in which the aliquots were placed under a UV lamp (λ = 365 nm) for 1 min. Following UV irradiation, samples were mixed 1:1 with 2× SDS gel-loading buffer and analysed by SDS-PAGE and western blotting with anti-LPS and anti-His 5 antibodies as described above. Purification and reconstitution of E. coli LptB 2 FGC complexes. E. coli LptB 2 FGC-His complexes containing wild-type LptF, LptF(S157C), LptF(I234C) or LptF(S157C/I234C) were prepared by a method similar to that described above for the E. cloacae homologues. C43 E. coli containing pCDFduet-LptB-LptFG (or the appropriate LptF mutant) and pBADHisA-LptC-tbn-His 7 were diluted from overnight cultures into fresh LB supplemented with 50 μg/ml carbenicillin and 50 μg/ml spectinomycin and grown at 37 °C. All cultures of cells containing pCDFduet-LptB-LptF(S157C/I234C)G were supplemented with 0.4% w/v glucose. At A 600 nm ~ 0.8, wild-type LptF, LptF(S157C) and LptF(I234C) cultures were cooled to 20 °C, induced by addition of 200 μM IPTG and 0.02% w/v larabinose, and protein expression was carried out for 16 h. Cultures expressing the LptF(S157C/I234C) variant were cooled to 30 °C, induced and protein expressed for 12 h. Thereafter, purification of wild-type and cysteine-mutant LptB 2 FGC-His complexes was identical to that for wild-type E. cloacae LptB 2 FGC-His except that 0.5 mM THP was omitted from all buffers. E. coli LptA(I36pBPA)-His was purified as previously described 4, 10 .
E. coli LptB 2 FGC-His complexes containing pBPA-substituted LptC, LptC(M19pBPA, G21pBPA or F78pBPA) were expressed in C43 cells containing pCDFduet-LptB-LptFG, pBADHisA-LptC-tbn-His 7 and pSup-BpaRS-6TRN as described above for wild-type complexes, except that 0.7 mM pBPA was added to the medium 15 min before induction. Purification of pBPA-substituted E. coli LptB 2 FGC-His complexes was performed in the same manner as for the wildtype proteins.
Purified LptB 2 FGC complexes were incorporated into liposomes containing LPS by the detergent-dilution method as described 4 . LPS release from those liposomes to soluble LptA(I36pBPA) was carried out as described above, except that in reactions in which it was present 5 mM DTT was added to the liposome mixture 15 min before the addition of ATP-Mg. Complementation and outer-membrane-permeability assays with LptF cysteine mutants. Growth conditions. Strains were grown in lysogeny broth (LB Lennox; Fisher Bioreagents) at 37 °C with aeration for liquid cultures and supplemented with 1.5% agar (DifcoTM; Becton Dickinson) for solid medium. When necessary, medium was supplemented with 125 μg/ml ampicillin (Sigma-Aldrich), 0.16 mM IPTG (Gold Biotechnology), and 33 μg/ml X-Gal (Gold Biotechnology). Strains are listed in Supplementary Table 2 . Mutant construction. Plasmids encoding LptF variants were generated by sitedirected mutagenesis PCR using the pBAD18LptFG3 plasmid 36 as template, Phusion polymerase (Fischer Scientific) and the primers listed in Supplementary  Table 1 (Sigma-Aldrich). Complementation testing and generation of haploid strains was carried out as previously described 27, 36 .
Outer-membrane-permeability assays. Assessment of outer-membrane permeability was carried out by disc-diffusion assay with bacitracin, novobiocin, rifampin and erythromycin discs (Becton Dickinson), as previously described 11 .
Immunoblotting. Levels for Flag-tagged LptF variants were determined by immunoblotting whole-cell lysates normalized by A 600 nm with 1:10,000 dilution of anti-Flag monoclonal antibody (Sigma-Aldrich) and horseradish peroxidase conjugated with a 1:10,000 dilution of anti-mouse antibody (GE Healthcare Life Sciences), as previously described 27 . Measurement of ATP hydrolysis by LptB 2 FGC in liposomes. LptF cysteine mutants. ATPase assays were done using a the EnzChek Phosphate Assay Kit (Molecular Probes) at 30 °C as previously reported 37 . A 90-μl reaction mixture containing 20 μl of the supplied substrate, 1 μl of the supplied enzyme, 28 mM Tris (pH 8.0), 304 mM NaCl, 6.7% glycerol, 5.6 mM ATP and 2.2 mM MgCl 2 was incubated at room temperature for 5 min to allow the consumption of contaminating phosphate. Reactions were initiated by the addition of 10 μl proteoliposomes solution, and the absorbance at wavelength of 360 nm was monitored using an Epoch microplate spectrophotometer. Rates are the slope of the linear region of the product formation graph. Error bars indicate the standard deviations of the rates measured over three biological and technical replicates. Measurement of ATP hydrolysis in liposomes. Comparison of LptB 2 FG, LptB 2 FGC and LptB 2 FG-LptC(ΔTM). ATPase activity was assayed using a modified molybdate method, as previously reported 38 . All assays were done in 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 10% glycerol (final concentrations). Reactions contained 60% proteoliposomes by volume (prepared as described above, thawed on ice). The remaining volume was composed of Tris-HCl, NaCl and glycerol, such that the final concentrations would be the values listed above. Soluble LptC was added at the indicated molar rations and incubated with the proteoliposomes for 15 min on ice. Reactions were initiated at 30 °C with the addition of ATP-MgCl 2 (5 mM ATP, 2 mM MgCl 2 ). Aliquots were taken at 0, 20, 40, and 60 min and were quenched with an equal volume of 12% SDS (Sigma). Inorganic phosphate was measured using the reported method 38 . Absorbance values were measured using a Spectramax Plus 384 plate reader (Molecular Devices). The experiment was repeated three times for each condition. For analysis, linear lines of best fit were calculated for each replicate dataset. Plotted data represents the mean value of the slopes and the error bars indicate the standard deviation. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data Availability
Coordinates and structure factors have been deposited in the Protein Data Bank under accession numbers 6MIT for the E. cloacae LptB 2 FGC and 6MJP for the V. cholerae LptB 2 FGC structure. 
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Extended Data Fig. 1 | Purification and Table of results from assays that tested the ability of plasmids encoding E. coli LptF variants to complement a ΔlptF strain. b, To assess whether the LptF double-cysteine mutant was being expressed and translated properly, we measured LptF-Flag levels by anti-Flag western blot in whole-cell lysates from merodiploid E. coli strains containing either pBAD18-LptF-Flag or pBAD18-LptF(S157C/ I234C)-Flag. c, Disc diffusion assays were carried out to assess the outermembrane permeability (relative to wild type) of E. coli strains expressing only plasmid-encoded LptF variants. Values denote the diameter (in mm) of regions with no growth, and values in parentheses denote regions of inhibited growth. Discs were 6 mm in diameter. d, Disc diffusion assays were performed as in c, except that experiments were performed in merodiploid strains with wild-type chromosomal copies of lptFG. Alleles are listed as follows: plasmid-encoded lptFG alleles, a solidus and then the chromosome-encoded lptFG alleles. e, Coomassie-stained samples of purified LptB 2 FGC used in the LPS release assay: (1) LptF-Flag;
(2) LptF(S157C)-Flag; (3) LptF(I234C)-Flag; and (4) LptF(S157C/I234C)-Flag. LptC contained a C-terminal thrombin-cleavable His 7 tag used for nickel-affinity chromatography, which was cleaved before reconstitution into liposomes. f, The ATPase activity of E. coli LptB 2 FGC reconstituted into liposomes was assessed by measuring the rate of phosphate release over time. Data are mean ± s.d. of results from three technical replicates, each of two biological replicates, except two replicates that were performed with one LptB(E163Q) 2 Polder map contoured at 2.5σ. c, Ordered PEG400 at the interface of V. cholerae LptB and LptG, with the 2F o − F c map contoured at 1.0σ and carved at 2.0 Å. d, View of the lumen between the transmembrane helices of LptC (purple), LptF (green) and LptG (teal), looking towards the inner membrane from the periplasm. The 2F o − F c map is contoured at 1.0σ (blue mesh) and the F o − F c map is contoured at 3.0σ (green and red meshes). e, View of the same region from within the membrane, with LptF helices in the foreground clipped away; the perspective is approximated by the teal arrow at the top right of d.
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